Frontlight ResearchEarly access
Haemophilia trials in Japan
9 of 13 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleSafety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Where
- Iruma-gun, Nagoya, Sapporo, Suginami-Ku
- Age
- 18 years and over
- People
- 173 worldwide
- Run by
- Pfizer
See details and how to joinNCT05568719 - Phase 3Taking peopleClinical Trial of NXT007 for the Prophylactic Treatment of Hemophilia A in Infants and Children
- Where
- Kawasaki-shi
- Age
- 0 years to 17 years
- People
- 50
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07838194 · EU 2026-526103-29-00 - Phase 4Taking peopleEfanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
- Where
- Hiroshima, Kawasaki, Saitama, Tokyo
- Age
- 12 years and over
- People
- 35 worldwide
- Run by
- Sanofi
See details and how to joinNCT06941870 - Phase 3Taking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Where
- Kashihara-shi, Maebashi, Nagoya, Suginami-Ku
- Age
- 12 years and over
- People
- 360 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416604 · EU 2025-522435-33-00 - Phase 3Not yet taking people in JapanA Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
- Where
- Hirakata-shi, Osaka, Maebashi-shi, Gunma, Nara, Niigata-shi, Niigata, Nishinomiya-shi, Hyogo, Tokyo
- Age
- 18 years and over
- People
- 84 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07830732 · EU 2026-525529-19-00 - Phase 3Taking peopleOpen-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Where
- Azumino, Hiroshima, Kashihara, Lruma-gun, Nagoya, Saga, Saitama-shi
- Age
- 1 year to 74 years
- People
- 245 worldwide
- Run by
- Pfizer
See details and how to joinNCT05145127 · EU 2022-500470-33-00 - Phase 3Taking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
- Where
- Kashihara-shi, Shinjuku-ku
- Age
- 12 years and over
- People
- 138 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416526 · EU 2025-522434-32-00 - Phase 3Taking peopleA Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
- Where
- Azumino, Kashihara, Kobe, Saga, Saitama-Shi
- Age
- 1 year to 17 years
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05611801 · EU 2022-500495-65-00 - Phase 2Taking peopleA Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia
- Where
- Bunkyo Ku, Osaka, Sapporo, Sendai
- Age
- 18 years to 79 years
- People
- 7
- Run by
- Kiminori Kimura, MD
See details and how to joinNCT07681089